89bio Inc (NASDAQ:ETNB)’s traded shares stood at 1.14 million during the latest session, with the company’s beta value hitting 1.53. At the last check today, the stock’s price was $9.69, to imply a decrease of -3.49% or -$0.35 in intraday trading. The ETNB share’s 52-week high remains $11.84, putting it -22.19% down since that peak but still an impressive 57.07% since price per share fell to its 52-week low of $4.16.
Analysts have given a consensus recommendation of Buy for 89bio Inc (ETNB), translating to a mean rating of 1.36. Of 8 analyst(s) looking at the stock, 0 analyst(s) give ETNB a Sell rating. 1 of those analysts rate the stock as Overweight while 0 advise Hold as 7 recommend it as a Buy.
89bio Inc (NASDAQ:ETNB) trade information
After registering a -3.49% downside in the latest session, 89bio Inc (ETNB) has traded red over the past five days. The 5-day price performance for the stock is -2.71%, and 24.23% over 30 days. With these gigs, the year-to-date price performance is 23.91%.
The extremes give us $12 and $29 for target low and target high price respectively. As such, ETNB has been trading -199.28% off suggested target high and -23.84% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 32.21% for the past 5-year period. While 2025 is set for a 40.34% return in earnings, projections for the next 5 years are at 13.99% annually.
ETNB Dividends
89bio Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is JANUS HENDERSON GROUP PLC with 13.28 million shares, or about 13.2986% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $106.32 million.
